<DOC>
	<DOCNO>NCT01798680</DOCNO>
	<brief_summary>The purpose study determine efficacy safety vitamin D3 ( cholecalciferol ) supplementation HIV progression incidence pulmonary tuberculosis among HIV-positive Tanzanian adult men woman initiate highly active antiretroviral therapy ( HAART ) .</brief_summary>
	<brief_title>Trial Vitamin D HIV Progression</brief_title>
	<detailed_description>HIV-infected adult initiate antiretroviral therapy resource-limited setting experience high mortality , pulmonary tuberculosis , comorbidity rate first year HIV treatment . Observational study show low vitamin D risk factor HIV progression incidence pulmonary tuberculosis among adult initiate HAART ; however , whether relationship causal vitamin D supplementation start HAART initiation improve health outcome determine . This study randomize , double-blind , placebo-controlled trial conduct examine effect vitamin D3 supplementation morality pulmonary tuberculosis adult initiate HAART . Participants HIV-positive Tanzanian men woman age 18 year old , initiate HAART time randomization whose baseline 25-hydroxyvitamin D ( 25 ( OH ) D ) concentration &lt; 30ng/mL . Eligible individual randomize receive ) vitamin D3 regimen consist 50,000 IU vitamin D3 take orally per week 4 week ( week 0 , 1 , 2 , 3 ) follow 2,000 IU vitamin D3 supplement take orally per day start 4 week study discharge 12 month b ) placebo pill take weekly 4 week ( week 0 , 1 , 2 , 3 ) follow placebo pill take daily start 4 week study discharge . Participants follow 12 month ART initiation .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>HIVpositive Men Women 18 Years Age old Initiating HAART time randomization 25 ( OH ) D concentration &lt; 30 ng/mL HAART initiation Pregnant Women Enrolled another micronutrient trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>